FGF2 and Hyperglycemia: Furthermore, local hyperglycemia and advanced glycation end products (AGEs) in diabetic patients may promote glycosylated FGF-2 production, which inhibits the proliferation of endothelial cells and has negative effects on wound healing [21,28].